Início › Lúpus › Flórida

Ensaios clínicos de Lúpus em Flórida

23 estudos para Lúpus estão buscando participantes em locais em Flórida.

Cidades em Flórida

Texto oficial do estudo (Inglês)

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Arthritis & Rheumatic Disease Specialties, Aventura
Clinical Research of West Florida 1, Clearwater
Avanti Clinical Research Corp, Hialeah
e mais 5

RecrutandoFase 3

Idades de 18 a 75 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07438496

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Clinical Research Of West Florida - Phase I Unit /ID# 279292, Clearwater
Finlay Medical Research - Greenacres /ID# 278380, Greenacres City
Clinical Research of Osceola /ID# 278374, Kissimmee
e mais 3

RecrutandoFase 1

Idades de 18 a 75 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07607964

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Research Site, Brandon
Research Site, Miami
Research Site, Miami

RecrutandoFase 3

Idades de 18 a 70 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07430306

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Research Site, Plantation

RecrutandoFase 1

Idades de 18 a 65 · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07201558

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

AARDS Research, Inc., Aventura
Meris Clinical Research-Brandon-69466, Brandon
Clinical Research of West Florida, Inc., Clearwater
e mais 2

RecrutandoFase 2

Idades de 18 a 74 · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07409181

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Omega Research Debary, LLC, DeBary
South Florida Rheumatology, Hollywood
GTL Medical And Research Group, Miami
e mais 2

RecrutandoFase 3

Idades de 18 a 75 · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07355218

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

GNP Research, Cooper City
University of Florida Clinical Research Center, Gainesville
Miami Dermatology and Laser Research, Miami
e mais 1

RecrutandoFase 2

Idades de 12 a 70 · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07570862

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

GNP Research at Mark Jaffe, MD, Cooper City
Advance Medical Research Center, Miami
Diverse Clinical Research LLC, Miami
e mais 2

RecrutandoFase 3

Idades de 18 a 75 · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07332481

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Mayo Clinic, Jacksonville

RecrutandoFase 1

Idades de 18 a 74 · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT07085104

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sl0044 50239, Brandon
Sl0044 50630, Clearwater
Sl0044 50751, Coral Gables
e mais 9

RecrutandoFase 3

Idades 16 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06617325

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Centre for Rheumatology, Immunology and Arthritis, Fort Lauderdale
South Florida Rheumatology, Hollywood
LIFE Clinical Trials, Margate
e mais 1

RecrutandoEstudo observacional

Idades 16 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07175285

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Mayo Clinic, Jacksonville

RecrutandoFase 1/2

Idades de 18 a 65 · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06121297

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

Bioresearch Partner Coral Terrace, South Miami

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06570798

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

Highlands Advanced Rheumatology And Arthritis Center - Avon Park /ID# 278239, Avon Park
Clinical Research Of West Florida - Phase I Unit /ID# 275834, Clearwater
Life Clinical Trials - Colonial Drive - Margate /ID# 276050, Margate
e mais 1

RecrutandoFase 1

Idades de 18 a 75 · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT06977724

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Royal Research Corp, Hollywood
Mayo Clinic Jacksonville, Jacksonville
Florida Kidney Physicians, Riverview
e mais 1

RecrutandoFase 2

Idades de 18 a 100 · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT05268289

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Dolphin Medical Research, Doral
Alloy Clinical Research LLC, Kissimmee
SouthCoast Research Center, Miami
e mais 4

RecrutandoFase 3

Idades de 18 a 75 · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT07201129

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Investigative Site, Clearwater
Investigative Site, DeBary
Investigative Site, Tampa

RecrutandoFase 2

Idades de 18 a 80 · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT07260877

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Clinical Res Of W Florida, Clearwater
GNP Research, Cooper City
IRIS Research and Development, Plantation
e mais 1

RecrutandoFase 3

Idades de 12 a 100 · Todos os sexos · Atualizado em 8 de jul. de 2026 · NCT06133972

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

Omega Research Group, Orlando

RecrutandoFase 1

Idades de 18 a 70 · Todos os sexos · Atualizado em 5 de jun. de 2026 · NCT06613360

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

US03-0, Clearwater
US05-0, Orlando

RecrutandoFase 1/2Voluntários saudáveis bem-vindos

Idades de 18 a 70 · Todos os sexos · Atualizado em 2 de jun. de 2026 · NCT06625671

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

University of Florida, Gainesville
Nicklaus Children's Hospital, Miami

RecrutandoFase 1

Idades de 12 a 70 · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT06308978

Lupus Landmark Study: A Prospective Registry and Biorepository

University of Miami, Miami

RecrutandoEstudo observacional

Idades de 18 a 110 · Todos os sexos · Atualizado em 15 de abr. de 2026 · NCT05934149

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

IRIS Research and Development, LLC, Plantation

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2024 · NCT06581562

Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.